Creutzfeldt-Jakob disease - Treatment with human pituitary growth hormone Factor
Last reviewed for CCPS 15 May 1998.
Preliminary questions [16283]
16373 [1] there is some evidence that treatment with human pituitary growth hormone may be a factor in the development of the condition under consideration.
16287 [1] the veteran has had treatment with human pituitary growth hormone at some time. the veteran had treatment with human pituitary growth hormone before the clinical onset of Creutzfeldt-Jakob disease. 16289 — the veteran has established the causal connection between the treatment with human pituitary growth hormone and VEA service for Creutzfeldt-Jakob disease. 16292 — the veteran has established the causal connection between the treatment with human pituitary growth hormone and operational service for the clinical onset of Creutzfeldt-Jakob disease. or 16293 — the veteran has established the causal connection between the treatment with human pituitary growth hormone and eligible service for the clinical onset of Creutzfeldt-Jakob disease. Clinical onset and operational service [16292] or 16295 — the identified illness or injury for which treatment with human pituitary growth hormone was given is causally related to operational service. [5] [6] Clinical onset and eligible service [16293]
16296 — the identified illness or injury for which treatment with human pituitary growth hormone was given is causally related to eligible service. [8] [6]
Links
[1] https://clik.dva.gov.au/ccpsf005rc-6
[2] clikpopup://CCPS/reject16287No
[3] clikpopup://CCPS/reject16288No
[4] clikpopup://CCPS/reject24913No
[5] clikpopup://CCPS/reject16294No
[6] clikpopup://CCPS/reject16295,16296No
[7] clikpopup://CCPS/Treatment with human growth hormone before CJD onset for illness
[8] clikpopup://CCPS/reject16296No